24/9 update: Gozellix has received US CMS transitional pass-through (TPT) status, effective from 1 Oct-25.
Transitional pass through (TPT) status allows for a separate payment in addition to payment for imaging in the outpatient setting.
22/9 update: Buy with a stop-loss at $14.10
You're not a member! Trial today
